Human Health and Ecological Risk Assessment for the Operation of the Explosives Waste Treatment Facility at Site 300 of the Lawrence Livermore National Laboratory, Volume 1: Report of Results

Human health and ecological risk assessments are required as part of the Resource Recovery and Conservation Act (RCRA) permit renewal process for waste treatment units. This risk assessment is prepared in support of the RCRA permit renewal for the Explosives Waste Treatment Facility (EWTF) at Site 300 of the Lawrence Livermore National Laboratory (LLNL). The human health risk assessment is based on U.S. Environmental Protection Agency- (U.S. EPA) approved emissions factors and on California Environmental Protection Agency (CalEPA), California Air Resources Board (CARB) and U.S. EPA assessment and air dispersion models. This risk assessment identifies the receptors of concern and evaluates theoretical carcinogenic risk, and theoretical acute and chronic non-carcinogenic hazard, following those guidelines. The carcinogenic risk to a 30-year resident at the maximum off-site receptor location is 0.0000006 or 0.6 in 1 million. The carcinogenic risk to a 25-year worker at the maximum bystander on-site receptor location is also 0.0000006 or 0.6 in 1 million. Any risk of less than 1 in a million is below the level of regulatory concern. The acute non-carcinogenic hazard for the 30-year resident is 0.01, and the chronic non-carcinogenic hazard is 0.01. The acute non-carcinogenic hazard for the 25-year worker is 0.3, and the chronic non-carcinogenic hazard is 0.2. The point of comparison for acute and chronic non-carcinogenic hazard is 1.0; an estimate less than 1.0 is below the level of regulatory concern. The estimates of health effects are based on health conservative assumptions and represent an upper bound of the possible exposures to the receptors. Based on these results, emissions from the operations of the EWTF should not be of concern for human health. For the ecological risk assessment (ERA), 10 receptor species (including plants), representing members of the trophic levels in the habitat of Site 300, were evaluated for the possibility of potential detrimental effects from EWTF emissions. The ecological hazard quotients (EHQs) at a location closest to the EWTF suggest a potential for adverse consequences. However, the conservatisms incorporated into the analysis may overestimate potential consequences and may explain the potential for impacts. Using less conservative values suggests that there is a possibility for limited to no additional impact to occur from the continuing operation of the EWTF

Environmental Monitoring Plan, Revision 6

The purpose of environmental monitoring is to promote the early identification of, and response to, potential adverse environmental impacts associated with Lawrence Livermore National Laboratory (LLNL) operations. Environmental monitoring supports the Integrated Safety Management System (ISMS), International Organization for Standardization (ISO) 14001 Environmental Management Systems standard, and U. S. Department of Energy (DOE) Order 458.1, Radiation Protection of the Public and the Environment. Specifically, environmental monitoring enables LLNL to detect, characterize, and respond to releases from LLNL activities; assess impacts; estimate dispersal patterns in the environment; characterize the pathways of exposure to members of the public; characterize the exposures and doses to individuals and to the population; and to evaluate the potential impacts to the biota in the vicinity of LLNL. Environmental monitoring is also a major component of compliance demonstration for permits and other regulatory requirements. The Environmental Monitoring Plan (EMP) addresses the sample collection and analytical work supporting environmental monitoring to ensure the following: (1) A consistent system for collecting, assessing, and documenting environmental data of known and documented quality; (2) A validated and consistent approach for sampling and analysis of samples to ensure laboratory data meets program-specific needs and requirements within the framework of a performance-based approach for analytical laboratory work; and (3) An integrated sampling approach to avoid duplicative data collection. LLNL prepares the EMP because it provides an organizational framework for ensuring that environmental monitoring work, which is integral to the implementation of LLNL's Environmental Management System, is conducted appropriately. Furthermore, the Environmental Monitoring Plan helps LLNL ensure compliance with DOE Order 231.1 Change 2, Environment, Safety and Health Reporting, which require the publication of an annual report that characterizes the site's environmental management performance. To summarize, the general regulatory drivers for this environmental monitoring plan are ISO 14001, DOE Order 458.1, and DOE Order 231.1. The environmental monitoring addressed by this plan includes preoperational characterization and assessment, effluent and surveillance monitoring, and permit and regulatory compliance monitoring. Additional environmental monitoring is conducted at LLNL as part of compliance with the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA, also known as Superfund). LLNL coordinates its ground water surveillance monitoring program with the CERCLA monitoring program to gain sampling efficiencies

Global overview of the management of acute cholecystitis during the COVID-19 pandemic (CHOLECOVID study)

Background: This study provides a global overview of the management of patients with acute cholecystitis during the initial phase of the COVID-19 pandemic. Methods: CHOLECOVID is an international, multicentre, observational comparative study of patients admitted to hospital with acute cholecystitis during the COVID-19 pandemic. Data on management were collected for a 2-month study interval coincident with the WHO declaration of the SARS-CoV-2 pandemic and compared with an equivalent pre-pandemic time interval. Mediation analysis examined the influence of SARS-COV-2 infection on 30-day mortality. Results: This study collected data on 9783 patients with acute cholecystitis admitted to 247 hospitals across the world. The pandemic was associated with reduced availability of surgical workforce and operating facilities globally, a significant shift to worse severity of disease, and increased use of conservative management. There was a reduction (both absolute and proportionate) in the number of patients undergoing cholecystectomy from 3095 patients (56.2 per cent) pre-pandemic to 1998 patients (46.2 per cent) during the pandemic but there was no difference in 30-day all-cause mortality after cholecystectomy comparing the pre-pandemic interval with the pandemic (13 patients (0.4 per cent) pre-pandemic to 13 patients (0.6 per cent) pandemic; P = 0.355). In mediation analysis, an admission with acute cholecystitis during the pandemic was associated with a non-significant increased risk of death (OR 1.29, 95 per cent c.i. 0.93 to 1.79, P = 0.121). Conclusion: CHOLECOVID provides a unique overview of the treatment of patients with cholecystitis across the globe during the first months of the SARS-CoV-2 pandemic. The study highlights the need for system resilience in retention of elective surgical activity. Cholecystectomy was associated with a low risk of mortality and deferral of treatment results in an increase in avoidable morbidity that represents the non-COVID cost of this pandemic

Purification of cross-linked RNA-protein complexes by phenol-toluol extraction

Recent methodological advances allowed the identification of an increasing number of RNA-binding proteins (RBPs) and their RNA-binding sites. Most of those methods rely, however, on capturing proteins associated to polyadenylated RNAs which neglects RBPs bound to non-adenylate RNA classes (tRNA, rRNA, pre-mRNA) as well as the vast majority of species that lack poly-A tails in their mRNAs (including all archea and bacteria). We have developed the Phenol Toluol extraction (PTex) protocol that does not rely on a specific RNA sequence or motif for isolation of cross-linked ribonucleoproteins (RNPs), but rather purifies them based entirely on their physicochemical properties. PTex captures RBPs that bind to RNA as short as 30 nt, RNPs directly from animal tissue and can be used to simplify complex workflows such as PAR-CLIP. Finally, we provide a global RNA-bound proteome of human HEK293 cells and the bacterium Salmonella Typhimurium

Human Health and Ecological Risk Assessment for the Operation of the Explosives Waste Treatment Facility at Site 300 of the Lawrence Livermore National Laboratory, Volume 1: Report of Results

Human health and ecological risk assessments are required as part of the Resource Recovery and Conservation Act (RCRA) permit renewal process for waste treatment units. This risk assessment is prepared in support of the RCRA permit renewal for the Explosives Waste Treatment Facility at Site 300 of the Lawrence Livermore National Laboratory. The human health risk assessment is based on U.S. Environmental Protection Agency approved emissions factors and on California Environmental Protection Agency, Air Resources Board and U.S. Environmental Protection Agency risk assessment and air dispersion models. The risk assessment identifies receptors of concern and evaluates carcinogenic risk, and acute and chronic noncarcinogenic hazard. The carcinogenic risk to a 30-year resident at the maximum offsite receptor location is 0.0000006 or 0.6 in one million. The carcinogenic risk to a 25-year worker at the maximum bystander on-site receptor location is also 0.0000006 or 0.6 in one million. Any risk of less than 1 in a million is below the level of regulatory concern. The acute noncarcinogenic hazard for the 30-year resident is 0.02 and the chronic noncarcinogenic hazard is 0.01. The acute noncarcinogenic hazard for the 25-year worker is 0.3 and the chronic noncarcinogenic hazard is 0.2. The point of comparison for acute and chronic noncarcinogenic hazard is 1.0, an estimate less than 1.0 is below the level of regulatory concern. The estimates of health effects are based on health conservative assumptions and represent an upper bound of the possible exposures to the receptors. For the ecological risk assessment, four receptor species were evaluated for potential detrimental effects; none were found to be adversely affected because for each species the predicted ecological hazard quotients are always less than one. Based on these results, emissions from the operations of the Explosive Waste Treatment Facility should not be considered to be of concern for human health or ecological reasons

Environmental Monitoring Plan, Revision 5

The purpose of environmental monitoring is to promote the early identification of, and response to, potential adverse environmental impacts associated with Lawrence Livermore National Laboratory (LLNL) operations. Environmental monitoring supports the Integrated Safety Management System (ISMS), International Organization for Standardization (ISO) 14001 Environmental Management Systems standard, and U. S. Department of Energy (DOE) Order 450.1A, Environmental Protection Program. Specifically, in conformance with DOE Order 450.1A, Attachment 1, paragraph 1(b)(5), environmental monitoring enables LLNL to detect, characterize, and respond to releases from LLNL activities; assess impacts; estimate dispersal patterns in the environment; characterize the pathways of exposure to members of the public; characterize the exposures and doses to individuals and to the population; and to evaluate the potential impacts to the biota in the vicinity of LLNL. Environmental monitoring also serves to demonstrate compliance with permits and other regulatory requirements. The Environmental Monitoring Plan (EMP) addresses the sample collection and analytical work supporting environmental monitoring to ensure the following: (1) A consistent system for collecting, assessing, and documenting environmental data of known and documented quality. (2) A validated and consistent approach for sampling and analysis of samples to ensure laboratory data meets program-specific needs and requirements within the framework of a performance-based approach for analytical laboratory work. (3) An integrated sampling approach to avoid duplicative data collection. Until its cancellation in January 2003, DOE Order 5400.1 required the preparation of an environmental monitoring plan. Neither DOE Order 450.1A nor the ISO 14001 standard are as prescriptive as DOE Order 5400.1, in that neither expressly requires an EMP. However, LLNL continues to prepare the EMP because it provides an organizational framework for ensuring that this work, which is integral to the implementation of LLNL's Environmental Management System, is conducted appropriately. Furthermore, the Environmental Monitoring Plan helps LLNL ensure compliance with DOE Order 5400.5, Radiation Protection of the Public and the Environment, and DOE Order 231.1 Change 2, Environment, Safety and Health Reporting, which require the publication of an annual report that characterizes the site's environmental management performance. To summarize, the general regulatory drivers for this environmental monitoring plan are ISO 14001, DOE Order 450.1A, DOE Order 5400.5, and DOE Order 231.1. The environmental monitoring addressed by this plan includes preoperational characterization and assessment, effluent and surveillance monitoring, and permit and regulatory compliance monitoring. Additional environmental monitoring is conducted at LLNL as part of compliance with the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA, also known as Superfund). LLNL coordinates its ground water surveillance monitoring program with the CERCLA monitoring program to gain sampling efficiencies. (See LLNL [1992] and LLNL [2008] for information about LLNL's CERCLA activities)